DAKOTA DUKES: Open Payments
NPI 1992318430 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,499 in 60 payments from 21 companies in 2025. Trend: 2023 $1,811 · 2024 $2,796 · 2025 $1,499
Food & beverage: $1,499
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 10 | $174 |
| Boston Scientific Corporation | 4 | $167 |
| Dendreon Pharmaceuticals LLC | 6 | $158 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $137 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $134 |
| PFIZER INC. | 6 | $124 |
| UROGEN PHARMA, INC. | 4 | $94 |
| Janssen Biotech, Inc. | 3 | $81 |
| Novartis Pharmaceuticals Corporation | 3 | $75 |
| Merck Sharp & Dohme LLC | 2 | $66 |
Products named: XTANDI, PROVENGE, Nubeqa, Axonics, ERLEADA, PLUVICTO, KEYTRUDA, YONSA.
Industry payments across NC — which companies pay providers there.
